KALEIDO BIOSCIENCES, INC. Share-based Payment Arrangement, Expense
KALEIDO BIOSCIENCES, INC. reported Share-based Payment Arrangement, Expense of $10.34 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-04-01
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2019-12-31 was $2.23M, a 7.23% decline year-over-year.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2019-09-30 was $2.91M, a 23.89% decline year-over-year.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2019-06-30 was $2.40M, a 377.14% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2019-03-31 was $2.53M, a 980.34% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2021 was $10.34M, a 18.46% decline from fiscal 2020.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2020 was $12.68M, a 25.98% increase from fiscal 2019.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2019 was $10.07M, a 44.57% increase from fiscal 2018.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2018 was $6.96M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $10.34M 10-K · filed 2022-04-01 | |||
| 2020-12-31 | $12.68M 10-K · filed 2022-04-01 | |||
| 2019-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $5.14M derived: sum of 2 quarters · filed 2021-03-03 | $7.54M derived: sum of 3 quarters · filed 2021-03-03 | $10.07M 10-K · filed 2021-03-03 |
| 2019-09-30 | $2.91M 10-Q · filed 2019-10-30 | $5.31M derived: sum of 2 quarters · filed 2019-10-30 | $7.84M 10-Q · filed 2019-10-30 | $10.24M derived: sum of 4 quarters · filed 2020-03-02 |
| 2019-06-30 | $2.40M 10-Q · filed 2019-08-01 | $4.93M 10-Q · filed 2019-08-01 | $7.33M derived: sum of 3 quarters · filed 2020-03-02 | $11.15M derived: sum of 4 quarters · filed 2020-03-02 |
| 2019-03-31 | $2.53M 10-Q · filed 2019-05-02 | $4.93M derived: sum of 2 quarters · filed 2020-03-02 | $8.76M derived: sum of 3 quarters · filed 2020-03-02 | $9.26M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $6.23M derived: sum of 2 quarters · filed 2020-03-02 | $6.73M derived: sum of 3 quarters · filed 2020-03-02 | $6.96M 10-K · filed 2020-03-02 |
| 2018-09-30 | $3.82M 10-Q · filed 2019-10-30 | $4.33M derived: sum of 2 quarters · filed 2019-10-30 | $4.56M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $503.00K 10-Q · filed 2019-08-01 | $737.00K 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $234.00K 10-Q · filed 2019-05-02 |